Röchling Medical Division provides a variety of contract manufacturing services for plastic processing and precision...
Röchling Advent Tool & Mold has acquired the American medical technology specialist Precision Medical Products (PMP) based in Denver, Pennsylvania, US.
The Röchling Group is consistently continuing its strategy of expanding the medical division.
CEO of the Röchling Group and the person responsible for the medical division Professor Hanns-Peter Knaebel said: “This acquisition will allow us to significantly strengthen the position of Röchling as a provider of sophisticated medical technology products and implement our growth strategy in the US.
“Furthermore, we expect the acquisition to provide synergies with our other locations that are dealing with the issue of medical technology.”
He also pointed out that Precision Medical Products had acquired an excellent reputation in terms of quality and innovation.
He added: “This is an exact fit with the Röchling philosophy and a solid foundation for future success.”
PMP has more than 50 years of experience in the manufacture of medical equipment and around 100 years of experience in the development and manufacture of needles and other precision-manufactured metal products. Its range of services includes engineering services, metalworking, injection moulding, equipment assembly, packaging, and sterilisation.
The ability to manufacture high-quality precision components with extremely narrow tolerances and complete demanding projects to a high degree of quality has generated significant growth in the past.
PMP specialises in niche markets. Numerous renowned original equipment manufacturers (OEM) who outsource their manufacturing and design rely on PMP as a supplier. PMP has been working with some of these in close and trusting partnerships going back decades.
The products manufactured by PMP include autoinjectors (special syringes for anaphylactic shock), medical products (minimally invasive instruments for eye surgery), bifurcation needles (special needles for vaccinations and allergy testing) and special syringes for bone cement.
Knaebel explained: “The company fits perfectly with our strategy of strengthening our medical technology business in the US. It is a medium-sized, owner-managed company that will integrate well into the Röchling Group and be an excellent addition to the Group’s business. That was an extremely important factor in our decision.”
PMP is managed by an experienced management team that will oversee the integration of the company into the Röchling Group during a transition phase, he confirmed.
President and CEO of PMP Douglas N Yocom is convinced that absorption into the Röchling Group as an international leader has opened up extraordinary future prospects for his company and its employees. He is confident that it will allow strong growth and secure jobs. The company, which has 120 employees, was singled out three years in a row as one of the “Best Places to Work in Pennsylvania.
President of Röchling Advent Tool & Mold and head of the medical plastics business unit Lewis H. Carter said: “PMP employees have extensive experience in the design, development, manufacture and sale of plastic and metal precision components and assemblies for medical technology worldwide. We were very impressed by this expertise.”
Röchling Advent Tool & Mold has been part of the Röchling Group since 2012. Based in Rochester, New York State, the company was formerly the only Röchling Medical location in North America. It is a full-service specialist in the manufacture of injection-molded plastic precision components for medical technology.
According to Carter, the two companies will complement each other perfectly. He said: “The combination of our injection molding expertise with PMP’s expertise in metal and fine precision technology will enable us to offer medical technology manufacturers in North America a broader range of services than before.”
He also explained that existing markets would be served extremely effectively, and the company would be able to tap into new markets. The customer structures have also dovetailed each other. In addition, the production technologies of Advent opened up the possibility of manufacturing a component previously outsourced by PMP in-house in future.
Other strengths of PMP include a strong focus on quality and innovation, a complete package from one source and a highly modern and representative production location in Denver, Pennsylvania. Roughly 1,900m2 of the nearly 10,000m2 production halls are used as cleanrooms.
This is where medical products are assembled, manufactured and packaged in ISO-certified clean room areas in classes 7 and 8. There are modern office spaces across two floors.
Carter explained: “There is enough space to expand in all areas within the existing plant. There is also the option of giving the location a general expansion.”
The Medical division of the Röchling Group offers customers a wide range of standard and tailored plastic products in the fields of pharmaceuticals, diagnostics, surgery and life sciences. These high-quality products are used in innovative drug delivery systems, primary packaging systems, surgical instruments and disposable diagnostic items.
Röchling Medical has announced it will be showcasing its products and services at the Propack...
Röchling Medical has announced it will be attending two key pharmaceutical industry events (CPhI Worldwide...
Röchling Medical has ceremoniously marked the expansion of its site in Neuhaus am Rennweg, Germany....